Shire Lower Over Profit Share

An SEC filing revealed that Shire Plc (SHPGY) will only receive a 42% share of profits from the attention deficity hyperactivity disorder treatment the company developed with New River Pharmaceuticals sending the stock price plunging $4.06 to close at $53.10.